Literature DB >> 15879569

Patients with a family history of cancer: identification and management.

Margaret M Eberl1, Annette Y Sunga, Carolyn D Farrell, Martin C Mahoney.   

Abstract

A family history of certain malignancies, especially breast, ovarian, colorectal, and prostate cancers, can place persons at increased risk of developing these cancers. By constructing a pedigree that includes 3 generations, family physicians can identify patients at increased risk because of family cancer history. Persons at increased cancer risk because of family history warrant a surveillance strategy for early detection. Genetic professionals represent an important resource in assessing genetic risk and possible testing. Persons identified as being at increased risk of various cancers based on their family history should understand the surveillance plan that is recommended and the importance of maintaining a healthy lifestyle and remaining up to date on other cancer screening tests.

Entities:  

Mesh:

Year:  2005        PMID: 15879569     DOI: 10.3122/jabfm.18.3.211

Source DB:  PubMed          Journal:  J Am Board Fam Pract        ISSN: 0893-8652


  12 in total

1.  Digital Family History Data Mining with Neural Networks: A Pilot Study.

Authors:  Robert Hoyt; Steven Linnville; Stephen Thaler; Jeffrey Moore
Journal:  Perspect Health Inf Manag       Date:  2016-01-01

2.  Coherence and completeness of population-based family cancer reports.

Authors:  Louise Wideroff; Anne O Garceau; Mark H Greene; Marsha Dunn; Timothy McNeel; Phuong Mai; Gordon Willis; Lou Gonsalves; Michael Martin; Barry I Graubard
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2010-02-16       Impact factor: 4.254

3.  Issues associated with a hereditary risk of cancer: Knowledge, attitudes and practices of nurses in oncology settings.

Authors:  Johanne Hébert; Anne-Sophie Bergeron; Anne-Marie Veillette; Karine Bouchard; Hermann Nabi; Michel Dorval
Journal:  Can Oncol Nurs J       Date:  2022-04-01

4. 

Authors:  Johanne Hébert; Anne-Sophie Bergeron; Anne-Marie Veillette; Karine Bouchard; Hermann Nabi; Michel Dorval
Journal:  Can Oncol Nurs J       Date:  2022-04-01

5.  Consistency of self-reported first-degree family history of cancer in a population-based study.

Authors:  Fernanda Lenara Roth; Suzi Alves Camey; Maira Caleffi; Lavínia Schuler-Faccini; Edenir Inêz Palmero; Carla Bochi; Susana Mayer Moreira; Luciane Kalakun; Roberto Giugliani; Patrícia Ashton-Prolla
Journal:  Fam Cancer       Date:  2009-01-20       Impact factor: 2.375

6.  Cancer family history reporting: impact of method and psychosocial factors.

Authors:  Kimberly M Kelly; Randi Shedlosky-Shoemaker; Kyle Porter; Amber Remy; Philip DeSimone; Michael A Andrykowski
Journal:  J Genet Couns       Date:  2007-02-23       Impact factor: 2.717

7.  Various types and management of breast cancer: an overview.

Authors:  Ganesh N Sharma; Rahul Dave; Jyotsana Sanadya; Piush Sharma; K K Sharma
Journal:  J Adv Pharm Technol Res       Date:  2010-04

8.  Development and validation of a simple questionnaire for the identification of hereditary breast cancer in primary care.

Authors:  Patricia Ashton-Prolla; Juliana Giacomazzi; Aishameriane V Schmidt; Fernanda L Roth; Edenir I Palmero; Luciane Kalakun; Ernestina S Aguiar; Susana M Moreira; Erica Batassini; Vanessa Belo-Reyes; Lavinia Schuler-Faccini; Roberto Giugliani; Maira Caleffi; Suzi Alves Camey
Journal:  BMC Cancer       Date:  2009-08-14       Impact factor: 4.430

9.  Patient interest in recording family histories of cancer via the Internet.

Authors:  Christian Simon; Louise Acheson; Christopher Burant; Nancy Gerson; Sarah Schramm; Susan Lewis; Georgia Wiesner
Journal:  Genet Med       Date:  2008-12       Impact factor: 8.822

10.  Effects of genetically engineered stem cells expressing cytosine deaminase and interferon-beta or carboxyl esterase on the growth of LNCaP rrostate cancer cells.

Authors:  Bo-Rim Yi; Kyung-A Hwang; Yun-Bae Kim; Seung U Kim; Kyung-Chul Choi
Journal:  Int J Mol Sci       Date:  2012-09-28       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.